Market Overview 2023-2028:
The global eClinical solutions market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 17.9 Billion by 2028, exhibiting a growth rate (CAGR) of 12.3% during 2023-2028. The extensive research and development activities conducted by biopharma and pharma companies, the increasing incorporation of software solutions in clinical trials, and the growing need for safety monitoring represent some key factors driving the market.
eClinical solutions refer to using technology to manage and analyze clinical data in clinical research. These solutions help streamline the clinical trial process, making it faster, more efficient, and cost-effective. They include electronic data capture (EDC), clinical trial management systems (CTMS), randomization and trial supply management (RTSM), and electronic patient-reported outcomes (ePRO), among others. Electronic data capture (EDC) allows for real-time data collection, reducing the time and resources required for manual data entry. Clinical trial management systems (CTMS) help to streamline the trial management process, making it easier to manage timelines, budgets, and study sites. Electronic patient-reported outcomes (ePRO) allow patients to report their symptoms and outcomes directly, thus improving patient engagement and compliance. Randomization and trial supply management (RTSM) help to ensure that study participants receive the correct treatment and supplies, reducing waste and improving efficiency. These solutions offer various benefits, including improved data quality, increased efficiency, reduced errors, and better compliance with regulations. They help researchers to gain insights into the data collected during clinical trials, making it easier to identify trends, outliers, and potential safety issues. They also aid in reducing the costs associated with clinical trials, such as travel expenses, paper-based data collection, and data entry.
eClinical Solutions Market Trends:
The increasing demand for technologically advanced solutions to manage clinical trials is significantly contributing to the market growth. In line with this, the rapid adoption of EDC and CDMS solutions and the growing need for remote patient monitoring and telemedicine are positively influencing the market. Furthermore, the rising number of clinical trials and the escalating need for faster drug development is catalyzing the market. Apart from this, the growing regulatory scrutiny over clinical trial data and the increasing requirement for accurate and reliable data are propelling the market. Moreover, eClinical solutions can reduce the costs associated with clinical trial management by eliminating paper-based processes and minimizing the need for manual data entry. This, in turn, is expected to fuel the market expansion. Besides, the increasing importance of patient-centric trials and the rapid adoption of cloud-based solutions are favoring the market. In addition, the rising integration of AI and ML algorithms to identify trends and patterns in data and improve decision-making is strengthening the market. Some of the other factors driving the market include significant growth in the biopharmaceutical industries, the increasing prevalence of chronic diseases, the growing geriatric population, the escalating adoption of smart medical devices, continual improvements in the healthcare infrastructure, and rapid technological advancements.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global eClinical solutions market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, delivery mode, development phase and end use.
- EDC and CDMS
- Clinical Data Integration Platforms
- Safety Solutions
- Clinical Analytics Platforms
The report has provided a detailed breakup and analysis of the eClinical solutions market based on the product. This includes eCOA, EDC and CDMS, Clinical Data Integration Platforms, Safety Solutions, CTMS, RTSM, eTMF, and Clinical Analytics Platforms. Among these, CTMS represented the largest segment.
Delivery Mode Insights:
- Web-hosted (On-demand)
- Licensed Enterprise (On-premises)
A detailed breakup and analysis of the eClinical solutions market based on the delivery mode has also been provided in the report. This includes web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based. Among these, web-hosted (on-demand) represented the largest segment.
Development Phase Insights:
- Phase I
- Phase II
- Phase III
- Phase IV
A detailed breakup and analysis of the eClinical solutions market based on the development phase has also been provided in the report. This includes Phase I, Phase II, Phase III, and Phase IV. Among these, phase III accounted for the largest market share.
End Use Insights:
- Contract Research Organization
- Academic Institutes
- Pharma and Biotech Organizations
A detailed breakup and analysis of the eClinical solutions market based on the end use has also been provided in the report. This includes hospitals, contract research organization, academic institutes, pharma and biotech organizations, and others. Among these, contract research organization accounted for the largest market share.
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for eClinical solutions. Some of the factors driving the North America eClinical solutions market included the rising prevalence of chronic disorders and the growing need for remote patient monitoring and telemedicine.
The report has also provided a comprehensive analysis of the competitive landscape in the global eClinical solutions market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Anju Software Inc., Clario, Fountayn, eClinical Solutions LLC, eClinicalWorks, Oracle Corporation, PAREXEL International Corporation and Signant Health. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
||Product, Delivery Mode, Development Phase, End Use, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Anju Software Inc., Clario, Fountayn, eClinical Solutions LLC, eClinicalWorks, Oracle Corporation, PAREXEL International Corporation and Signant Health
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global eClinical solutions market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global eClinical solutions market?
- What is the impact of each driver, restraint, and opportunity on the global eClinical solutions market?
- What are the key regional markets?
- Which countries represent the most attractive eClinical solutions market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the eClinical solutions market?
- What is the breakup of the market based on the delivery mode?
- Which is the most attractive delivery mode in the eClinical solutions market?
- What is the breakup of the market based on the development phase?
- Which is the most attractive development phase in the eClinical solutions market?
- What is the breakup of the market based on the end use?
- Which is the most attractive end use in the eClinical solutions market?
- What is the competitive structure of the global eClinical solutions market?
- Who are the key players/companies in the global eClinical solutions market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the eClinical solutions market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global eClinical solutions market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the eClinical solutions industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.